Published in Cancer Weekly, May 22nd, 2006
"The aim of this study was to determine if ex-vivo and in-vivo technique of lymphatic mapping for CRC result in similar sentinel lymph node (SLN) identification and accuracy rates. Thirty consecutive patients with 32 CCR underwent in vivo SLN mapping. After completion of the colectomy, we remapped the SLN in the operative specimens from patients who had undergone successful in vivo lymphatic mapping," researchers in France reported.
"At least 1 SLN was identified by in vivo approach in 32 tumours; 1.5 SLNs (1-3) and 1.8 SLNs (1-4) (p=.24) were identified by the in vivo and the ex...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.